It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 | Hyderabad, Telangana, India | ActiveEekshana Pharmaceuticals Private Limited, a active private limited company, was established on 02 March 2016 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100TG2016PTC103602. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Venu Madhav Nallapati (Director), Ramanjaneyulu Bajantri (Director). Past directors included Venu Madhav Nallapati, Harinath Badam. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Tirumala Towers, H.No.16-2-677/2, Inward No:16 Block No.2, Judges Colony, Malakpet, Hyderabad, Telangana, 500036.
U24100TG2016PTC103602
103602
02 March 2016
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Eekshana Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venu Madhav Nallapati | Director | 01 Apr 2021 | Current |
| Ramanjaneyulu Bajantri | Director | 02 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 15 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eekshana Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.39% decrease. The company also saw a slight decrease in profitability, with a 2.7% decrease in profit. The company's net worth Soared by an impressive increase of 16.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Eekshana Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Eekshana Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Eekshana Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eekshana Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Eekshana Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Eekshana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Venu Madhav Nallapati was appointed as a Director was appointed as a Director on 01 Apr 2021 & has been associated with this company since 4 years 8 months . was completed.
Progress on Ramanjaneyulu Bajantri was appointed as a Director was appointed as a Director on 02 Mar 2016 & has been associated with this company since 9 years 9 months . was documented.
The activity Eekshana Pharmaceuticals Private Limited was registered on 02 Mar 2016 with Roc Hyderabad & aged 9 years 9 months as per MCA records. was completed.
The CIN of Eekshana Pharmaceuticals Private Limited is U24100TG2016PTC103602.
Eekshana Pharmaceuticals Private Limited is headquartered at Tirumala Towers, H.No.16-2-677/2, Inward No:16 Block No.2, Judges Colony, Malakpet, Hyderabad, Telangana, 500036.
Eekshana Pharmaceuticals Private Limited was incorporated on 02 March 2016.
The current directors of Eekshana Pharmaceuticals Private Limited are
The primary industry of Eekshana Pharmaceuticals Private Limited is Trade.
Eekshana Pharmaceuticals Private Limited is unlisted.
The authorized capital of Eekshana Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Eekshana Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX